The Synergy Factor: Trauma and Cancer
Hunter D Alexander1, Sai Krishna Bhogadi1, Omar Hejazi1
1Division of Trauma, Critical Care, Burns, and Emergency Surgery, Department of Surgery, College of Medicine, University of Arizona, Tucson, Arizona.
The Journal of Surgical Research
|August 17, 2024
Summary
Trauma patients with cancer face significantly higher risks of deep vein thrombosis and mortality. Targeted care pathways are crucial for improving outcomes in this vulnerable population.
Area of Science:
- Trauma Surgery
- Oncology
- Clinical Outcomes Research
Background:
- Trauma and cancer are leading causes of death in the US.
- Limited data exists on the impact of cancer on trauma patient outcomes.
- This study addresses the knowledge gap regarding cancer's influence on trauma patient outcomes.
Purpose of the Study:
- To determine the impact of cancer on the outcomes of adult trauma patients.
- To compare complication and mortality rates between trauma patients with and without cancer.
- To identify specific risks associated with cancer in trauma patients.
Main Methods:
- Retrospective analysis of the American College of Surgeons-Trauma Quality Improvement Program (2019-2021).
- Inclusion of adult trauma patients (≥18 years), excluding severe head injuries and nonmelanomatous skin cancers.
- Propensity score matching (1:3) to compare cancer (C) and no cancer (No-C) groups, analyzing complications and mortality.
Main Results:
- A matched cohort of 3236 patients (809 cancer, 2427 no cancer) was analyzed.
- Cancer patients had higher rates of deep vein thrombosis (1.1% vs. 0.3%, P=0.004).
- Cancer patients experienced significantly higher mortality (7.5% vs. 2.7%, P<0.001) but similar overall complication rates.
Conclusions:
- Trauma patients with cancer have nearly four times higher odds of deep vein thrombosis.
- Cancer patients face three times higher odds of mortality following trauma.
- Developing specialized care pathways for cancer patients undergoing trauma is essential for improving outcomes.
Related Concept Videos
Psychoneuroimmunology: Diabetes and Cancer
27
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
27
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K


